HUTCHMED (China) (HMDCF) Short term Debt (2015 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Short term Debt came in at $22.4 million in Q2 2026, down 12.49% year-over-year from $25.6 million in Q2 2025, and down 10.27% quarter-over-quarter from $25.0 million in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Short term Debt (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Short term Debt for 12 consecutive years, with $22.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Short term Debt fell 12.49% year-over-year to $22.4 million in Q2 2026; TTM through Jun 2026 was $22.4 million, a 12.49% decrease from a year earlier, with the FY2025 full-year figure at $25.0 million, down 69.84% from the prior year.
- Short term Debt was $22.4 million for Q2 2026 at HUTCHMED (China), down from $25.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $82.8 million in Q4 2024 and troughed at $18.1 million in Q4 2022.
- A 5-year average of $40.0 million and a median of $25.6 million in 2025 frame the typical range for Short term Debt.
- Across the five-year window, Short term Debt soared 338.27% in 2023 and sank 69.84% in 2025, its largest moves.
- Over 5 years, Short term Debt stood at $18.1 million in 2022, then soared by 338.27% to $79.3 million in 2023, then advanced by 4.36% to $82.8 million in 2024, then slumped by 69.84% to $25.0 million in 2025, then declined by 10.27% to $22.4 million in 2026.
- The last three Short term Debt figures came in at $22.4 million (Q2 2026), $25.0 million (Q4 2025), and $25.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.41 Mn |
| Dec 31, 2025 | 24.97 Mn |
| Jun 30, 2025 | 25.60 Mn |
| Dec 31, 2024 | 82.81 Mn |
| Jun 30, 2024 | 26.47 Mn |
| Dec 31, 2023 | 79.34 Mn |
| Dec 31, 2022 | 18.10 Mn |
| Dec 31, 2021 | 26.91 Mn |
| Jun 30, 2021 | 26.88 Mn |
| Dec 31, 2020 | 26.86 Mn |
| Sep 30, 2019 | 1.50 Mn |
| Jun 30, 2019 | 2.80 Mn |
| Mar 31, 2019 | 7.42 Mn |
| Dec 31, 2018 | 6.51 Mn |
| Dec 31, 2017 | 1.55 Mn |
| Jun 30, 2017 | 5.40 Mn |
| Dec 31, 2016 | 19.96 Mn |
| Dec 31, 2015 | 23.08 Mn |